Ad
related to: abbvie pharmaceuticals- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- Read AbbVie Stories
Search results
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks via Yahoo Finance· 5 days agopharmaceutical companies. It is designed to provide capital appreciation by thoroughly evaluating...
Why Investors Are Eyeing AbbVie Inc (ABBV): The Key Drivers of M
Guru Focus· 5 days agoAbbVie Inc (ABBV, Financial) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial performance and promising growth ...
AbbVie Hit With Investor Lawsuit Over Director Removal Bylaw
Bloomberg Law· 5 days agois the latest company facing a legal challenge to a bylaw that gives its board the power to oust individual members over errors, omissions, or lies in their paperwork. The proposed class action ...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 3 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 1 day agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 4 days agoZacks Rank Teva currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks...
Top law firms in US opioid lawsuits to get hundreds of millions in fees
KFGO· 13 hours agoBy Brendan Pierson (Reuters) - A court-appointed panel on Friday recommended how to divvy up a pool of $2.13 billion in legal fees from nationwide drug industry settlements over the U.S. opioid ...
Top law firms in US opioid lawsuits to get hundreds of millions in fees
Reuters· 13 hours ago, opens new tab a pool of $2.13 billion in legal fees from nationwide drug industry settlements over the U.S. opioid crisis, with top firms set to receive hundreds of millions of dollars. Other ...
Oppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating By Investing.com
Investing.com· 2 days agoOppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating
3 Dividend Stocks You May Want To Double Down On
Benzinga via Yahoo Finance· 4 days agoSometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....
Ad
related to: abbvie pharmaceuticals